Neurogene (NGNE) Stock Forecast, Price Target & Predictions
NGNE Stock Forecast
Neurogene stock forecast is as follows: an average price target of $46.67 (represents a 106.14% upside from NGNE’s last price of $22.64) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
NGNE Price Target
The average price target for Neurogene (NGNE) is $46.67 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $49.00 to $45.00. This represents a potential 106.14% upside from NGNE's last price of $22.64.
NGNE Analyst Ratings
According to 3 Wall Street analysts, Neurogene's rating consensus is 'Buy'. The analyst rating breakdown for NGNE stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Neurogene Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | Paul Matteis | Stifel Nicolaus | $46.00 | $15.33 | 200.07% | 103.18% |
| Nov 19, 2024 | Keith Tapper | BMO Capital | $45.00 | $35.59 | 26.44% | 98.76% |
| Nov 12, 2024 | Keith Tapper | BMO Capital | $60.00 | $64.48 | -6.95% | 165.02% |
| Nov 12, 2024 | Paul Matteis | Stifel Nicolaus | $60.00 | $64.48 | -6.95% | 165.02% |
| Aug 12, 2024 | Mitchell Kapoor | H.C. Wainwright | $49.00 | $35.59 | 37.68% | 116.43% |
| Jun 26, 2024 | Keith Tapper | BMO Capital | $65.00 | $32.01 | 103.06% | 187.10% |
| Jun 10, 2024 | Joel Beatty | Robert W. Baird | $54.00 | $37.35 | 44.58% | 138.52% |
| May 13, 2024 | Mitchel Kapoor | H.C. Wainwright | $51.00 | $30.26 | 68.54% | 125.27% |
The latest Neurogene stock forecast, released on Nov 20, 2024 by Paul Matteis from Stifel Nicolaus, set a price target of $46.00, which represents a 200.07% increase from the stock price at the time of the forecast ($15.33), and a 103.18% increase from NGNE last price ($22.64).
Neurogene Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 4 | 8 |
| Avg Price Target | $45.50 | $52.75 | $53.75 |
| Last Closing Price | $22.64 | $22.64 | $22.64 |
| Upside/Downside | 100.97% | 132.99% | 137.41% |
In the current month, the average price target of Neurogene stock is $45.50, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 100.97% increase as opposed to Neurogene's last price of $22.64. This month's average price target is down -13.74% compared to last quarter, and down -15.35% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 19, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Oct 16, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Aug 14, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Aug 12, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Jun 26, 2024 | BMO Capital | Outperform | Initialise | |
| Jun 20, 2024 | William Blair | Outperform | Outperform | Hold |
| May 13, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Neurogene's last stock rating was published by BMO Capital on Nov 19, 2024. The company gave NGNE a "Outperform" rating, the same as its previous rate.
Neurogene Financial Forecast
Neurogene Revenue Forecast
| Revenue |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| # Analysts |
| Surprise % |
Neurogene's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. NGNE's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Neurogene EBITDA Forecast
| # Analysts |
| EBITDA |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
undefined analysts predict NGNE's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Neurogene's previous annual EBITDA (undefined) of $NaN.
Neurogene Net Income Forecast
| # Analysts |
| Net Income |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Neurogene's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NGNE's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Neurogene SG&A Forecast
| # Analysts |
| SG&A |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Neurogene's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to NGNE last annual SG&A of $NaN (undefined).
Neurogene EPS Forecast
| # Analysts |
| EPS |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
According to undefined Wall Street analysts, Neurogene's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NGNE previous annual EPS of $NaN (undefined).